Nandini Sadasivam/LinkedIn
Nov 9, 2026, 13:07
Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
Nandini Sadasivam, Consultant Haematologist at Manchester Royal Infirmary, shared a post on LinkedIn:
“It has been a fantastic 2 days at Vienna, networking with colleagues across the globe and sharing the UK Perspective and Manchester University NHS Foundation Trust Real World Experience of Treating Genetherapy in SCD and Thalassaemia at the Global Platform.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke
-
Nov 9, 2026, 12:40Dimpy Modi: Pilot Trial Protocol Investigates Liberal vs. Restrictive Red Blood Cell Transfusion in Leukemia
-
Nov 9, 2026, 12:37Rachel Rosovsky: Pregnancy and Pulmonary Embolism Management Within a Multidisciplinary PERT Framework